Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

University Ghent

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Procedure: Pharmaceutical care at baseline and follow-up visits over 6 months

Study type: Interventional

Funder types: Other

Identifiers

NCT00277732

2005/340

Details and patient eligibility

About

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to the control group ( = no input from pharmacist) or intervention group ( = with pharmaceutical care at baseline and follow-up visits over 6 months).

Enrollment: 288 patients

Sex: All

Ages: 45 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 45-75 years
• Body Mass Index >= 25
• Diabetes treatment for at least 12 months
• Regular visitors of the participating community pharmacy

Exclusion criteria

• Patients taking only insulin (no oral antidiabetic drugs)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)